To be fair he isn’t downramping in the sense that he believes the assays will come back with poor results, he’s downramping the lead-up to assays where there’s nothing to hold the price up hence the downward movement.
I wanted in cheaper and I’m going to get it. Let’s see what the drillbit says?
